ISpecimen Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

ISpecimen Stock Summary

ISpecimen competes with Fonar, Castle Biosciences, Exagen, OncoCyte Corp, and Personalis. iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts. Ispecimen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

ISpecimen Key Financial Ratios

ISpecimen Key Balance Sheet Accounts

ISpecimen Key Income Statement Accounts

ISpecimen Key Cash Accounts

ISpecimen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ISpecimen's current stock value. Our valuation model uses many indicators to compare ISpecimen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ISpecimen competition to find correlations between indicators driving ISpecimen's intrinsic value. More Info.iSpecimen is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, ISpecimen's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ISpecimen's earnings, one of the primary drivers of an investment's value.

iSpecimen Systematic Risk

Today, most investors in ISpecimen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ISpecimen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ISpecimen growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of ISpecimen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of iSpecimen. We use our internally-developed statistical techniques to arrive at the intrinsic value of iSpecimen based on widely used predictive technical indicators. In general, we focus on analyzing ISpecimen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ISpecimen's daily price indicators and compare them against related drivers.

When running ISpecimen's price analysis, check to measure ISpecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISpecimen is operating at the current time. Most of ISpecimen's value examination focuses on studying past and present price action to predict the probability of ISpecimen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISpecimen's price. Additionally, you may evaluate how the addition of ISpecimen to your portfolios can decrease your overall portfolio volatility.